The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
The aim of the study was to assess of the influence of atorvastatin on selected indicators of an inflammatory condition, function of the left ventricle and factors affecting the occurrence of undesired events like rehospitalizations and mortality in patients with dilated cardiomyopathy.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle in Patients With Dilated Cardiomyopathy|
- left ventricular function [ Time Frame: 2 months ] [ Designated as safety issue: No ]
- mortality [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
|Study Start Date:||February 2007|
|Study Completion Date:||February 2009|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Patients were divided into two groups: A, who were administered atorvastatin 40 mg daily for two months and 10 mg for next 4 months; and group B, 4 who were treated according to current guidelines without statin therapy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01015144
|Principal Investigator:||Agata Bielecka-Dabrowa, PhD||Department of Hypertension UM Lodz|
|Study Director:||Maciej Banach, Assoc. Prof.||Department of Hypertension UM Lodz|